Hdfc Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 23-10-2026
NAV ₹19.92(R) -0.68% ₹20.66(D) -0.68%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 14.61% 26.46% -% -% -%
Direct 15.9% 27.97% -% -% -%
Benchmark
SIP (XIRR) Regular 14.45% 17.82% -% -% -%
Direct 15.75% 19.22% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 1976 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 23-10-2026

Scheme Name NAV Rupee Change Percent Change
HDFC Pharma and Healthcare Fund - IDCW Option 19.92
-0.1400
-0.6800%
HDFC Pharma and Healthcare Fund - Growth Option 19.92
-0.1400
-0.6800%
HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan 20.66
-0.1400
-0.6800%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 20.66
-0.1400
-0.6800%

Review Date: 23-10-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -9.77 -6.71
-9.62
-10.57 | -6.77 8 | 17 Good
3M Return % -3.29 -1.17
-4.57
-8.61 | -0.94 3 | 17 Very Good
6M Return % 10.51 10.59
7.53
1.25 | 12.54 4 | 17 Very Good
1Y Return % 14.61 13.35
6.13
-2.97 | 14.61 1 | 16 Very Good
3Y Return % 26.46 20.11
18.82
15.14 | 26.46 1 | 11 Very Good
1Y SIP Return % 14.45
6.25
-4.36 | 15.32 2 | 16 Very Good
3Y SIP Return % 17.82
9.33
4.30 | 17.82 1 | 11 Very Good
Return data last Updated On : Oct. 23, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -9.69 -6.71 -9.52 -10.48 | -6.67 8 | 17 Good
3M Return % -3.02 -1.17 -4.25 -8.29 | -0.61 5 | 17 Very Good
6M Return % 11.12 10.59 8.25 1.96 | 13.41 6 | 17 Good
1Y Return % 15.90 13.35 7.57 -1.58 | 15.90 1 | 16 Very Good
3Y Return % 27.97 20.11 20.28 16.36 | 27.97 1 | 11 Very Good
1Y SIP Return % 15.75 7.71 -2.98 | 17.17 2 | 16 Very Good
3Y SIP Return % 19.22 10.69 5.89 | 19.22 1 | 11 Very Good
Return data last Updated On : Oct. 23, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Hdfc Pharma And Healthcare Fund NAV Regular Growth Hdfc Pharma And Healthcare Fund NAV Direct Growth
23-10-2026 19.923 20.656
22-10-2026 20.06 20.797
21-10-2026 20.082 20.819
19-10-2026 20.215 20.956
16-10-2026 20.481 21.23
15-10-2026 20.476 21.224
14-10-2026 20.526 21.275
13-10-2026 20.742 21.498
12-10-2026 20.775 21.532
09-10-2026 20.805 21.561
08-10-2026 20.646 21.396
07-10-2026 21.149 21.916
06-10-2026 21.219 21.988
05-10-2026 21.016 21.777
01-10-2026 21.213 21.979
30-09-2026 21.181 21.944
29-09-2026 21.613 22.392
28-09-2026 21.54 22.315
25-09-2026 21.826 22.61
24-09-2026 21.916 22.702
23-09-2026 22.081 22.873

Fund Launch Date: 04/Oct/2023
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies
Fund Benchmark: BSE Healthcare Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.